The inclusion of epileptic patients only displaying overt seizures that respond to ASMs as well as the lack of extensive genetic tests (i.e., ApoE, MAPT, TREM2, CALHM1, etc.)and systematic vEEG monitoring diminishes the relevance of our results regarding AD-related hyperexcitability and epileptogenesis. This evidence concerns the gene APOE and Alzheimer disease.